VIC News - Vaccine & Immunotherapy Center

From the blog

PHOTO-2023-08-01-18-40-10

Nanna Sivamanoharan is an MD student at the University of Edinburgh Medical School who spent the summer working in the lab at VIC.

September 18, 2023

VIC Welcomes Summer Students for another Summer of Fruitful Research Work in the Lab

23023NewsUpdateimg

Recent FASEB publication from the VIC team presents a review on a potential comprehensive definition of a target product profile for optimizing islet cell transplantation for treating and potentially curing type 1 diabetes

B-cells-in-brain-injury---Twitter

Recent Publication in the Journal of Inflammation from Dr. Ruxandra Sîrbulescu

Sirbulescu-News-Post-61223

Congratulations to Dr. Ruxandra F. Sîrbulescu for her Promotion to Assistant Professor at Harvard Medical School

1-s2.0-S101113442300074X-gr3 (1)

Recent Research Publication from VIC’s Dr. Jeffrey Gelfand

We’re not ready for the next pandemic.

Customizing T Cell-Based Immunotherapies in a ‘SNAP’

Hangry Too VIC News Post IMG

New Research Shows That Bacteria Get “Hangry,” Too

A swapped genetic code prevents viral infections and gene transfer

James Adeosun is a student at Clare College of the University of Cambridge who spent the summer working in the lab at VIC.

Celebrating the 20th Year of Annual Research Program at VIC for Clare College Students

FASEB SUSAN RAJU PAUL

FASEB Journal publication from VIC’s Dr. Susan Raju Paul

February 17, 2023

NYTIMES_Callahn

NY Times Opinion Piece from Dr. Michael Callahan:

February 10, 2023

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity

January 17, 2023

VIC Update 1223

Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo

January 4, 2023

DAVID_ALAGPULINSA

Keystone Symposium selects Dr. Alagpulinsa for 2023 Fellows Program

December 12, 2022

eOD-GT8-60mer-WEB

Novel HIV vaccine approach shows promise in first-in-human clinical trial

December 12, 2022

Dr. Poznansky Gives an Invited Research Talk about Latest Advances at VIC

November 16, 2022

Screen Shot 2022-11-09 at 1.21.39 PM

Investigating Cancer Immunotherapy Effects on COVID-19 Outcomes

November 16, 2022

new approaches to needleless vaccine delivery

New approaches to needle-less vaccine delivery

November 4, 2022

Screen Shot 2022-11-03 at 2.46.25 PM

A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma

November 4, 2022

Cancer-seeking molecular delivery system could boost immunotherapy drug, research finds

October 24, 2022

VIC-polo-VII-2022-poster

VIC lab members enjoying social gatherings this summer.

September 8, 2022

DSC_1857VIC Update

Undergraduates enjoy a successful summer internship at VIC!

September 7, 2022

Cancer-Cell-Cover

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes.

September 7, 2022

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetti Immunity.

September 7, 2022

VIC-NEWs-WMIF-MGH

2022 WMIF | The Dr. Is In | Leveraging Novel Mechanisms for Vaccine and Immunotherapy Development

David-V-leaving-party-5-26-22

David Verrill Goodbye Event

EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever

COVID Vaccines, Therapeutics, Variants, Long COVID, Ability To Tackle the Next Pandemic

Screen-Shot-2022-04-26-at-12.52.09-PM

A new platform for immunotherapeutic RNA delivery to cancer cells

new-immune-cell-soldier-could-be-a-good-target-for-immunotherapy-360799-1280x720

Immune cell ‘Soldier’ identified as potential target for immunotherapy

VIC-News-Post-Dual-Drug-Treatment

Dual-drug treatment offers promise for advanced melanoma patients

« Prev 1 2 3 4 Next »

Tweets by VICatMGH